IRLAB - Resolutions at Annual General Meeting 2019
IRLAB Therapeutics AB’s Annual General Meeting 2019 was held today, Thursday April 25, 2019, in Göteborg. At the Annual General Meeting the following main matters were resolved.Disposition of the company’s results The disposition of the company’s results proposed by the Board was adopted by the Annual General Meeting. This means that the amount available to the Annual General Meeting, totaling SEK 393,671,108, shall be transferred in full and that no dividend shall be paid for the past fiscal year. Discharge from liability for the Board members and the Managing Director The Annual